Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

V-IMMUNE® for Primary Immunodeficiency: A Phase III Clinical Trial (VIP Study)

NCT06954441 is registered in ClinicalTrials.gov with On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. as lead sponsor.

NCT NCT06954441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06954441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
V-IMMUNE® for Primary Immunodeficiency: A Phase III Clinical Trial (VIP Study)
Lead sponsor
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.
Phase
Phase 3
Overall status
Recruiting
Start date
August 15, 2025
Completion date
February 27, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agammaglobulinemia, immunodeficiencies, primary immunodeficiencies (pid)